Neoadjuvant ADT with TULSA in the Treatment of Intermediate Risk Prostate Cancer
Neoadjuvant ADT with TULSA in the Treatment of Intermediate Risk Prostate Cancer
Active, not recruiting · NCT05917860 · Registry updated 2025-02-17Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Neoadjuvant ADT with TULSA in the Treatment of Intermediate Risk Prostate Cancer | Genital Diseases, Male Urogenital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, male reproductive organ cancer, male reproductive system disorder, neoplasm, prostate cancer, prostate disorder | Active, not recruiting | Phase 1 | 2025-02-17 | NCT05917860 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Turku University Hospital | 95 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Turku University Hospital | Turku | Finland | 8 |